Brief: Oasmia And Karolinska Institutet To Collaborate
March 3 (Reuters) - Oasmia Pharmaceutical AB OASM.ST :
* OASMIA AND KAROLINSKA INSTITUTET TO COLLABORATE ON THE
BIOLOGICAL POTENTIAL OF OASMIA’S PROPRIETARY DRUG DELIVERY
PLATFORM
* SIGNED AN AGREEMENT WITH KAROLINSKA INSTITUTET, STOCKHOLM,
SWEDEN.
* COLLABORATION WILL GENERATE NEW INFORMATION AIMING AT
DEVELOPMENT OF NEW THERAPEUTIC APIS
Source text for Eikon: ID:nMFN44dB7v
Further company coverage: OASM.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Vivesto AB
See all newsBrief: Vivesto Reports Positive Topline Results From Paccal Vet Study In Cats
Brief: Vivesto Says Topline Results For Paccal Vet 'Positive'
Brief: Vivesto Q2 Operating Loss At SEK 8.6 Mln
Brief: Vivesto: Positive Results From Exploratory Study With Cantrixil
Brief: Vivesto Appoints Björn Svanström As CFO